Skip to Content

ETFMG Treatments Testing and Adv ETF GERM

Medalist Rating as of | See ETF Managers Investment Hub

Morningstar’s Analysis GERM

Will GERM outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of a middling Process Pillar rating and a Low People Pillar rating limit ETFMG Treatments Testing and Adv ETF to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings GERM

  • Current Portfolio Date
  • Equity Holdings 61
  • Bond Holdings 0
  • Other Holdings 2
  • % Assets in Top 10 Holdings 50.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

US DOLLARS

7.05
866,227
Cash and Equivalents
6.85
840,838
Healthcare
5.52
677,689
Healthcare
5.46
670,930
Healthcare
4.72
579,832
Healthcare
4.65
571,242
Healthcare
4.25
521,806
Healthcare
4.09
501,691
Healthcare
3.89
478,052
Healthcare